Hypertension and diabetes are commonly associated and strongly predispose to renal
injuries. In general,
antihypertensive therapies protect from these damages, but the effect of
cicletanine, a new type of
antihypertensive drug, is unknown. This study examines the effects of
cicletanine on
renal failure in spontaneously hypertensive rats with diabetes (SHRD).
Diabetes mellitus was induced with
streptozotocin in uninephrectomized SHR. Rats received the vehicle, 10 mg or 50 mg/kg per day of
cicletanine for 6 weeks. Age-matched untreated Wistar-Kyoto rats were used as controls. Systolic blood pressure (SBP), microalbuminuria and
proteinuria were assessed throughout the treatment. At the end of the study,
creatinine clearance measurements and histological analysis of kidneys were performed.
Cicletanine did not affect SBP but decreased the elevated
albuminuria of diabetic SHR in a dose-dependent manner. Similar results were obtained for
proteinuria. Treatment with the high dose of
cicletanine also normalized the altered
creatinine clearance of diabetic SHR. These results indicate that
cicletanine has a renal-protective action, probably blood pressure-independent, in a model combining
hypertension and diabetes. The mechanism of renal-protection of
cicletanine is not clearly established but may be due to the stimulation of arterial
prostacyclin synthesis and/or to the reduction of intraglomerular capillary pressure.